News from abbott A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 18, 2014, 09:00 ET

Abbott to Present at J.P. Morgan Healthcare Conference

 Abbott (NYSE: ABT) will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2015. Thomas C. Freyman,...

Dec 15, 2014, 09:00 ET

Abbott Commences Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022

Abbott (NYSE: ABT) today announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"),...

Dec 12, 2014, 11:18 ET

Abbott Announces Increase in Quarterly Dividend

 The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to $0.24 per share from $0.22 per...

Dec 12, 2014, 00:00 ET

Abbott Completes Acquisition of Veropharm

 Abbott (NYSE: ABT) today announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer. Abbott has had a...

Dec 11, 2014, 03:00 ET

Abbotts wegweisende Plattform für die Diagnostik von Infektionskrankheiten, IRIDICA, jetzt auch in Europa

-  IRIDICA hat das Potenzial, die Art und Weise zu ändern, wie Pathogene, die schwere Infektionen wie Sepsis und Pneumonie auslösen,...

Dec 11, 2014, 03:00 ET

IRIDICA, la plataforma de pruebas pionera de Abbott para enfermedades infecciosas, ya está disponible en Europa

- IRIDICA puede cambiar la forma de detectar e identificar las causas de infecciones graves como la sepsis y la neumonía - Puede...

Dec 11, 2014, 03:00 ET

La plate-forme d'Abbott, IRIDICA, pionnière en matière d'analyses des maladies infectieuses désormais disponible en Europe

- IRIDICA est capable de changer la façon de détecter et d'identifier les causes d'infections graves, comme la septicémie et la...

Dec 11, 2014, 03:00 ET
Abbott’s pioneering, infectious disease testing platform, IRIDICA, is now available in Europe and other CE-Mark recognized countries.

Abbott's Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe

 Abbott (NYSE: ABT) today announced its innovative diagnostic platform, known as IRIDICA, is now available in Europe and other CE-Mark...

Dec 04, 2014, 11:00 ET

Impact of Malnutrition in U.S. at $157 Billion Annually

 Even in food-abundant industrialized countries like the U.S., an alarming number of people, particularly seniors, are in a state of...

Nov 17, 2014, 10:00 ET
Better nutrition can improve the quality of life

People with Chronic Obstructive Pulmonary Disease (COPD) Who Received Nutrition Treatment in the Hospital Had Better Health Outcomes

People aged 65 and older, who were being treated for chronic obstructive pulmonary disease (COPD) in the hospital and received nutrition treatment...

Nov 04, 2014, 09:00 ET

Abbott to Present at Credit Suisse 2014 Healthcare Conference

Abbott (NYSE: ABT) will participate in the Credit Suisse 2014 Healthcare Conference on Tuesday, Nov. 11, 2014. Thomas C. Freyman, executive vice...

Oct 29, 2014, 09:30 ET

Abbott Expands Its Medical Device Business with Acquisition in Catheter-Based Electrophysiology Market

Abbott (NYSE: ABT) today announced that it has entered into an agreement to purchase Topera, Inc., a private, venture-backed medical device company...

Oct 22, 2014, 07:31 ET

Abbott Reports Third-Quarter 2014 Results

 Abbott today announced financial results for the third quarter ended Sept. 30, 2014. - Diluted EPS, excluding specified items, was...

Oct 20, 2014, 11:00 ET

New Large-Scale Study Will Look at How Nutrition Can Help Keep Patients from Returning to the Hospital

 At a time when hospitals are under increasing pressure to improve patient outcomes, Advocate Health Care -- one of the nation's leading health...

Oct 16, 2014, 16:30 ET

Abbott Acknowledged by Science Magazine as a Top Employer

Abbott (NYSE: ABT) today was named one of the Top 20 Employers by the journal Science. The global healthcare company ranked No. 12 overall,...

Oct 10, 2014, 10:36 ET

Abbott Celebrates the Power of Health and Achievement as First-Ever Title Sponsor of World Marathon Majors

Abbott (NYSE: ABT) and the World Marathon Majors announced a new partnership with Abbott becoming the race series' first-ever title sponsor....

Oct 01, 2014, 10:00 ET

Abbott Goes Extra Mile in Commitment to Helping People Live Healthy Lives as an Official Sponsor of 2014 Bank of America Chicago Marathon

 Abbott (NYSE: ABT) today announced a new partnership with the 2014 Bank of America Chicago Marathon, underscoring the company's...

Oct 01, 2014, 08:30 ET

Abbott Hosts Conference Call for Third-Quarter Earnings

 Abbott (NYSE: ABT) will announce its third-quarter 2014 financial results on Wednesday, Oct. 22, 2014, before the market opens. ...

Sep 26, 2014, 09:07 ET

Abbott culmina la adquisición de CFR Pharmaceuticals y anuncia los resultados de la OPA de las acciones de CFR

 Abbott ha adquirido el control de CFR Pharmaceuticals, duplicando con creces su presencia en el mercado de farmacéuticos genéricos...

Sep 26, 2014, 09:00 ET

Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares

 Abbott (NYSE: ABT) has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence...